Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay
Fred S. Apple, Stephen W Smith, Lesly A. Pearce, Mary Ann M. Murakami
Dive into the research topics of 'Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay'. Together they form a unique fingerprint.